Supplementary Data 1 Legend from Exploration of Immune-Modulatory Effects of Amivantamab in Combination with Pembrolizumab in Lung and Head and Neck Squamous Cell Carcinoma
Key Points
Key points are not available for this paper at this time.
Abstract
Data legend for supplementary data 1, showing the process chart and raw whole slide images of multiplex IHC.
اسأل الذكاء الاصطناعي
Like
Bookmark
Share
اسأل الذكاء الاصطناعي
Like
Bookmark
Share
Supplementary Data 1 Legend from Exploration of Immune-Modulatory Effects of Amivantamab in Combination with Pembrolizumab in Lung and Head and Neck Squamous Cell Carcinoma | Synapse